Alert: New Earnings Report (12/7/23)-Avid Bioservices Inc (NASDAQ: CDMO).


Avid Bioservices Inc (NASDAQ: CDMO) has reported a loss for its second fiscal quarter (ending October 31) of $-0.15 versus a loss $-0.02 for the same period a year ago. For the latest four quarters through October 31, E.P.S. were $-0.17 versus $1.92 for the same period a year ago — a decline of -109%.


Recent Price Action

Avid Bioservices Inc (NASDAQ: CDMO) stock closed at $5.29 on 12/7/23 after an increase of 1.7%. Moreover, this advance was accompanied by unusually high trading volume at 156% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 4.1% during the last week.

Current PriceTarget Research Rating

CDMO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.

Avid Bioservices has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Avid Bioservices has a very low Appreciation Score of 13 and a very low Power Rating of 0, with the Lowest Value Trend Rating the result.

Rating Review

In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.